Elevance Health, Inc.

ELV Healthcare Healthcare Plans

Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024.

Revenue
+1.42%
EPS
+17.9%
Free cash flow
+29.0%
Total debt
−3.65%

Quarter to September 2026, against a year earlier

414.18 0.58 +0.14%
Market cap
$89.4B
P/E
17.7×
Fwd P/E
18.7×
Dividend yield
1.66%
F-score
6/9
Altman Z
3.09
Beneish M
−2.26
Dividend safety
96/100

Elevance Health, Inc. 10-Q filed Oct 21, 2026

Fiscal Q3 2026 · Period ended Sep 30, 2026 · Filed · accepted 2:14 PM ET · Document on sec.gov · Filing index

What changed

Part II, Item 1A, Risk Factors, against the 10-Q filed Jul 15, 2026: no material changes, the filing says